| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2008 | CA2680104A1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 09/12/2008 | CA2680060A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | CA2680058A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity |
| 09/12/2008 | CA2680055A1 Novel 2-heteroaryl substituted indoles 695 |
| 09/12/2008 | CA2680038A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | CA2679965A1 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators |
| 09/12/2008 | CA2679944A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 09/12/2008 | CA2679937A1 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/12/2008 | CA2679936A1 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same |
| 09/12/2008 | CA2679919A1 Compositions and methods for delivery of anti-cancer agents |
| 09/12/2008 | CA2679917A1 Compositions and treatments for seizure-related disorders |
| 09/12/2008 | CA2679892A1 Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids |
| 09/12/2008 | CA2679844A1 Ppar active compounds |
| 09/12/2008 | CA2679817A1 Bipyridine carboxamide orexin receptor antagonists |
| 09/12/2008 | CA2679809A1 Benzimidazole derivatives and methods of use thereof |
| 09/12/2008 | CA2679807A1 Piperidine derivatives and methods of use thereof |
| 09/12/2008 | CA2679757A1 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof |
| 09/12/2008 | CA2679735A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor |
| 09/12/2008 | CA2679700A1 Mercaptopurine derivatives as anticancer agents |
| 09/12/2008 | CA2679690A1 Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity |
| 09/12/2008 | CA2679670A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 09/12/2008 | CA2679657A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections |
| 09/12/2008 | CA2679580A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 09/12/2008 | CA2679564A1 Aryl sulfonamides useful for modulation of the progesterone receptor |
| 09/12/2008 | CA2679520A1 Mineralcorticoid receptor antagonists for the treatment of endometriosis |
| 09/12/2008 | CA2679452A1 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 09/12/2008 | CA2679411A1 Ppar active compounds |
| 09/12/2008 | CA2679409A1 Rapid-disintegration monolayer film for the oral administration of active substances |
| 09/12/2008 | CA2679393A1 Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents |
| 09/12/2008 | CA2679388A1 Nucleic acid compounds for inhibiting ras gene expression and uses thereof |
| 09/12/2008 | CA2679387A1 Nucleic acid compounds for inhibiting akt gene expression and uses thereof |
| 09/12/2008 | CA2679380A1 Sulfonylated heterocycles useful for modulation of the progesterone receptor |
| 09/12/2008 | CA2679347A1 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof |
| 09/12/2008 | CA2679342A1 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof |
| 09/12/2008 | CA2679339A1 Nucleic acid compounds for inhibiting wnt gene expression and uses thereof |
| 09/12/2008 | CA2679316A1 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| 09/12/2008 | CA2679314A1 New compounds |
| 09/12/2008 | CA2679305A1 Pyrrole compounds |
| 09/12/2008 | CA2679301A1 Lisofylline analogs and methods for use in protecting pancreatic .beta.-cells, treating type 1 diabetes, and treating inflammatory and autoimmune diseases |
| 09/12/2008 | CA2679249A1 Compounds and compositions as modulators of gpr119 activity |
| 09/12/2008 | CA2679206A1 Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| 09/12/2008 | CA2679103A1 O6-alkylguanine-dna alkyltransferase inactivators |
| 09/12/2008 | CA2679101A1 Heterocyclic compounds, compositions comprising them and methods of their use |
| 09/12/2008 | CA2679039A1 Aminoamides as orexin antagonists |
| 09/12/2008 | CA2678895A1 Tricyclic compounds useful in treating iron disorders |
| 09/12/2008 | CA2678794A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/12/2008 | CA2678630A1 Synthesis of glyt-1 inhibitors |
| 09/12/2008 | CA2678555A1 Amelioration of cellular stress response |
| 09/12/2008 | CA2678492A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 09/12/2008 | CA2678463A1 Fused pyrimidinone compounds as mglur ligands |
| 09/12/2008 | CA2678424A1 Percutaneous administration device of bisoprolol |
| 09/12/2008 | CA2678367A1 Sustained release compositions using wax-like materials |
| 09/12/2008 | CA2678248A1 Quinolinone derivatives as parp and tank inhibitors |
| 09/12/2008 | CA2678100A1 Bicyclic oxomorpholine derivative |
| 09/12/2008 | CA2677076A1 Compositions comprising carisoprodol and methods of use thereof |
| 09/12/2008 | CA2675463A1 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology |
| 09/12/2008 | CA2675312A1 1-biarylazetidinone derivative |
| 09/12/2008 | CA2670539A1 Anesthetic spray composition |
| 09/12/2008 | CA2666461A1 Neuroprotective compositions and methods |
| 09/12/2008 | CA2656273A1 Prevention of nuclear, solar, and other radiation-induced tissue damage |
| 09/12/2008 | CA2621332A1 Pharmaceutical compositions comprising calcium dobesilate for the treatment of tendinitis |
| 09/11/2008 | US20080221548 Eradication of Pigmentation and Scar Tissue |
| 09/11/2008 | US20080221497 Filter membrane of polypheylacetylene, or cellulosic or chitin polymers modified with arginine, cysteine, or lysine side chains to remove toxic carbonyl compounds; diabetic and uremic dialysis patients |
| 09/11/2008 | US20080221221 Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization |
| 09/11/2008 | US20080221220 Antiinflammatory, antitumor and anticarcinogenic agents; rheumatic arthritis, psoriasis, transplant rejection, osteoporosis, Paget's disease, osteoarthritis, ankylosing spondylitis; 2',4'-dichloro-biphenyl-4-ylhydroxy or imine compounds |
| 09/11/2008 | US20080221219 Oleamide-containing composition for animal consumption |
| 09/11/2008 | US20080221218 Ligand binding member comprisingoligoamines covalently linked to an organic template; movement of oligoamines is conformationally restricted; oligoamines are same or different and are independently straight chained, cyclic or branched; phosphate binding in water purification; renal dialysis |
| 09/11/2008 | US20080221217 Phenyl Compounds and Their Use in the Treatment of Type II Diabetes |
| 09/11/2008 | US20080221216 Use of modafinil to treat spasticity |
| 09/11/2008 | US20080221215 Antiviral inhibition of capsid proteins |
| 09/11/2008 | US20080221214 Process for the preparation of "Urchym" a urease and alpha-chymotrypsin enzyme inhibitory drug |
| 09/11/2008 | US20080221213 Tablets Comprising a High Load of Strontium |
| 09/11/2008 | US20080221212 Diclofenac or salt; and penetration enhancer comprising N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate; transdermal; cosmetics; skin disorders |
| 09/11/2008 | US20080221211 Antiischemic agents; strokes |
| 09/11/2008 | US20080221210 3-(3,5-dibromo-4-{[3-(methylamino)benzyl]oxy}phenyl)propanoic acid; hypercholesterolemia, dyslipidemia, obesity, diabetes, atherosclerosis and cardiac diseases |
| 09/11/2008 | US20080221209 Psoriasis, alopecia, contact dermatitis, atopic dermatitis, allergies, vitiligo or inflammatory skin disorders; esterification reaction of oleyl alcohol and a stereoisomer of phenylglycine chloride hydrochloride in a polar aprotic solvent |
| 09/11/2008 | US20080221208 9-Cis- or 11-cis-retinyl succinate, citrate, ketoglutarate, fumarate, malate or oxaloacetate; administering to vertebrate having an endogenous retinoid deficiency; vision defects; 9-cis-retinyl acetate or 9-cis-retinyl succinate; photoreceptor stabilizers; macular degeneration |
| 09/11/2008 | US20080221207 Use of specific cyklolignans |
| 09/11/2008 | US20080221206 less anesthetic activity, but with more anti-inflammatory and spasmolytic activity; asthma, rhinitis, allergic urticaria, chronic lung inflammation associated with eosinophilia, following the example of atopic asthma and chronic intestinal inflammation, as colitis for instance |
| 09/11/2008 | US20080221205 effect on bone proliferation with the side effect reduced; degenerative bone disease and rheumatoid arthritis |
| 09/11/2008 | US20080221204 Materials and Methods for Treating Coagulation Disorders |
| 09/11/2008 | US20080221203 Use of Agonists and Antagonists of Beta Adrenoceptors for Treating Arterial Disease |
| 09/11/2008 | US20080221202 treatment of disorders and conditions modulated by at least one progesterone or glucocorticoid receptor; 11-(4-Dimethylamino-phenyl)-1-hydroxy-12a-methyl-1-prop-1-ynyl-1,3,4,4a,4b,5,6,9,10,11,12,12a-dodecahydro-2-oxa-chrysen-8-one |
| 09/11/2008 | US20080221201 4-(5-cyano-1-methyl-1H-pyrrol-2-yl)-N-methylbenzenesulfonamide; contraception, treating or preventing fibroids, uterine leiomyomata, endometriosis, dysfunctional bleeding, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake |
| 09/11/2008 | US20080221200 Dipeptidyl-peptidase (DPP) IV inhibitor N-peptidyl-O-aroyl hydroxylamine and immunosuppressor or immunomodulator; autoimmune diseases, graft rejection; antidiabetic agents; Alzheimer's, Parkinson's disease; obesity, retinopathy, nephropathy, neuropathy, schizophrenia; cognition activators |
| 09/11/2008 | US20080221199 Method for improving memory in mammals |
| 09/11/2008 | US20080221198 Novel Crystalline Forms of Antidiabetic Compounds |
| 09/11/2008 | US20080221197 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 09/11/2008 | US20080221196 Pharmaceutically active isoindoline derivatives |
| 09/11/2008 | US20080221195 N [(R)-1-Hydroxymethyl-2-(1H-indol-3-yl)-ethyl]-5-phenylethynyl-2-propoxy-benzamide; fertility control in men or in women, or for the prevention and/or treatment of osteoporosis; FSH antagonists |
| 09/11/2008 | US20080221194 Novel Potassium channel Blockers and Uses Thereof |
| 09/11/2008 | US20080221193 3-amino chromane derivatives |
| 09/11/2008 | US20080221192 3-(4-Methyl-imidazol-1-yl)-N-{3-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indol-6-ylamino]-phenyl}-5-trifluoromethyl-benzamide; including benign and malignant proliferative disorders as well as diseases resulting from inappropriate activation of the immune and nervous systems |
| 09/11/2008 | US20080221191 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens |
| 09/11/2008 | US20080221190 fungicides; good yields; steps require neither solvents nor reactants that are highly flammable and explosive, carcinogenic or corrosive; 1-chloro-4-chlorophenyl-2-butanol is reacted with the imidazole in toluene and aqueous sodium hydroxide solution in the presence of a phase transfer catalyst |
| 09/11/2008 | US20080221189 Rosacea, psoriasis, acute inflammation, chronic inflammation, septic shock, an autoimmune disease |
| 09/11/2008 | US20080221188 (S)(-)-2-(7-chloro-6-fluoro-1H-benzimidazol-1-yl)-N-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide; treatment of pain; vanilloid receptor inhibitor; Antagonists maintain analgesic properties, but avoid pungency and neurotoxicity side effects of agonists |
| 09/11/2008 | US20080221187 N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors |
| 09/11/2008 | US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds |
| 09/11/2008 | US20080221185 Psychoses, dementia or attention deficit disorder; 2-[3-(4-chlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl]-N-[2-(methyloxy)phenyl]acetamide |